Fundraising Fox
🦊/Companies
Sign in

HistoSonics

Ann Arbor, GB · Founded 2009 · Delaware corporation · 447 employees on LinkedIn · 9 known investors

Find your way into HistoSonics

137 people in our graph share verified history with the HistoSonics team — schools, employers, funds. One of them is your warm intro.

Kevin Morningstarunlockedknows M. Christine Gibbons · together at Michigan State University (overlapped)
knows the team · via Michigan State University
×5knows the team · via Kent State University
knows the team · via HistoSonics
×4knows the team · via Wayne State University

HistoSonics develops histotripsy technology, a non-invasive method that uses focused sound energy to destroy targeted tissue, offered as a medical device for physicians and their patients. The company markets its technology to healthcare providers internationally.

BiotechHardwareHealthtechMedical Devices

Founders & leadership

TDThomas Davison
Thomas DavisoninCo-Founder - Chairman CEO2009–2014Thomas Davison holds a Ph.D. in mammalian physiology from Kent State University and has founded or led multiple medical device companies including UltraCision (acquired by Ethicon), Endius (acquired by Zimmer), Sontra Medical (NASDAQ), and HistoSonics, where he served as co-founding Chairman and CEO.
MCM. Christine Gibbons
M. Christine GibbonsinCo-Founder / COO2017–2018Christine Gibbons is an executive and director at HistoSonics, a medical device company developing histotripsy technology for non-invasive tissue destruction. She has held roles in venture formation and early-stage company building across multiple technology ventures.
WC
Wen ChenNamed on SEC filing
TT
Tom TefftNamed on SEC filing
MB
Michael BlueNamed on SEC filing
FL
Fred LeeNamed on SEC filing

Board

GBGerry Brunk
Gerry BrunkinBoard Of Directors2019–2026Managing Director at Lumira Ventures
JAJim Adox
Jim AdoxinBoard MemberExecutive Managing Director at Clarevia Ventures
KK
Kadir KadhiresanBoard director
RM
Robert MorffBoard director
RCRenard Charity
Renard CharityinMember Board Of Directors2009–2018Managing Partner at Fletcher Spaght, Inc.
AV
Andrew Von EschenbachBoard director

Investors · 9

Alpha Wave GlobalMiami
Amzak HealthNew York
Early Stage Partners, LPCleveland
HealthQuest CapitalRedwood City
Lumira VenturesToronto · $1M – $10Mvia Gerry Brunk · board
Michigan Capital NetworkGrand Rapids
Bezos Expeditionsreported
Fletcher Spaght, Inc.reportedBostonvia Renard Charity · board
Hatteras Venture PartnersreportedResearch Triangle · $500K – $4M

Reported raises · per SEC filings

Form D private placements

$308.2M disclosed across 9 rounds · 2009–2024

▶$102MraisedAug 2024 · 39 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Fred Lee, Jr.Director
  • Gerry BrunkDirector
  • Wen ChenDirector
  • Michael BlueExecutive Officer, Director
  • V. Kadir KadhiresanDirector
  • Tom TefftDirector
  • Chris DimitropoulosDirector
  • Erica RogersDirector
  • James AdoxDirector
Offering amount
$102M
Amount sold
$102M
First sale
Jul 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$85MraisedDec 2022 · 38 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Wen ChenDirector
  • Tom TefftDirector
  • Michael BlueExecutive Officer, Director
  • Gerry BrunkDirector
  • Jim AdoxDirector
  • Kadir KadhiresanDirector
  • Fred LeeDirector
Offering amount
$85M
Amount sold
$85M
First sale
Dec 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$40.8MraisedJun 2020 · 24 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Gerry BrunkDirector
  • Michael BlueExecutive Officer, Director
  • Richard Eric BoslerExecutive Officer
  • James AdoxDirector
  • Thomas TefftDirector
  • Nikita KulkarniDirector
  • Fred LeeDirector
  • Wen ChenDirector
  • Kadir KadhiresanDirector
Offering amount
$40.8M
Amount sold
$40.8M
First sale
Apr 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$47.4MraisedApr 2019 · 44 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael BlueExecutive Officer, Director
  • James AdoxDirector
  • Fred LeeDirector
  • Gerry BrunkDirector
  • Gregory SorensenDirector
  • V. Kadir KadhiresanDirector
  • Tom TefftDirector
Offering amount
$47.4M
Amount sold
$47.4M
First sale
Apr 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7MraisedMar 2019 · 34 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert MorffDirector
  • Fred LeeDirector
  • Jon FreemanExecutive Officer
  • Josh KingExecutive Officer
  • Dan BulverExecutive Officer
  • Andrew Von EschenbachDirector
  • Mike DanielExecutive Officer
  • James AdoxDirector
  • Josh StopekDirector
  • Tom TefftDirector
  • Michael BlueExecutive Officer, Director
  • Akhil TripathiExecutive Officer
  • Linda TuftsDirector
Offering amount
$7M
Amount sold
$7M
Minimum investment
$6.2K
First sale
Apr 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.3MraisedFeb 2017 · 13 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert MorffDirector
  • Andrew Von EschenbachDirector
  • Fred Lee, Jr.Director
  • Michael BlueExecutive Officer, Director
  • M. Christine GibbonsExecutive Officer
  • Renard CharityDirector
  • James AdoxDirector
Offering amount
$13.3M
Amount sold
$8.3M
First sale
Jan 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.1MraisedAug 2015 · 10 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • M. Christine GibbonsExecutive Officer, Director
  • Thomas DavisonExecutive Officer, Director
  • James AdoxDirector
  • Robert MorffDirector
  • Andrew Von EschenbachDirector
  • Renard CharityDirector
Offering amount
$3M
Amount sold
$2.1M
Minimum investment
$15K
First sale
Jul 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedDec 2014 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Renard CharityDirector
  • Thomas DavisonExecutive Officer, Director
  • Robert MorffDirector
  • Andrew Von EschenbachDirector
  • M. Christine GibbonsExecutive Officer, Director
  • James AdoxDirector
Offering amount
$1.5M
Amount sold
$1.5M
Minimum investment
$18.8K
First sale
Dec 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
MD Anderson Cancer Center26 shared keywordsUT MD Anderson is a cancer research and treatment center that provides patient care, conducts research, and offers education in cancer prevention and treatment. It is part of the University of Texas System and operates as a nonprofit medical institution.

Companies competing with HistoSonics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does HistoSonics do?
HistoSonics develops histotripsy technology, a non-invasive method that uses focused sound energy to destroy targeted tissue, offered as a medical device for physicians and their patients. The company markets its technology to healthcare providers internationally.
Who are HistoSonics's investors?
HistoSonics's investors include Alpha Wave Global, Amzak Health, Early Stage Partners, LP, HealthQuest Capital, Lumira Ventures, Michigan Capital Network, Bezos Expeditions, Fletcher Spaght, Inc. and 1 more.
How much funding has HistoSonics raised?
HistoSonics has disclosed $308.2M raised across 9 rounds.
Where is HistoSonics headquartered?
HistoSonics is headquartered in Ann Arbor, GB.